New Drugs Penetrate Deep Into the Brain to Suppress Cravings

Click For Summary

SUMMARY

An NIH-funded study demonstrates that oral small-molecule GLP-1 receptor agonists penetrate deep into the brain to suppress hedonic feeding by modulating a distinct reward circuit in mice. Researchers utilized gene-editing techniques to create transgenic mice expressing humanized GLP-1 receptors, enabling precise drug testing on human receptor variants. This novel pathway differs from traditional appetite regulation mechanisms and suggests potential applications of GLP-1 drugs in treating reward-related disorders such as substance use disorder. The study highlights advanced biochemistry methods including transgenic mouse production for translational research.

PREREQUISITES

  • GLP-1 receptor pharmacology and signaling pathways
  • Transgenic mouse production and gene-editing techniques (e.g., CRISPR/Cas9)
  • Neurobiology of reward circuits and hedonic feeding
  • Small-molecule drug pharmacokinetics and blood-brain barrier penetration

NEXT STEPS

  • Study NIH research on GLP-1 receptor agonists and their CNS effects
  • Explore CRISPR/Cas9 applications for creating humanized transgenic mouse models
  • Investigate neurocircuitry involved in hedonic feeding and addiction
  • Review pharmacological strategies for targeting reward pathways in substance use disorders

USEFUL FOR

Neuroscientists, pharmacologists, biomedical researchers, and drug developers focused on obesity, addiction, and translational medicine will benefit from this discussion. It provides insights into advanced gene-editing models and novel mechanisms of GLP-1 drugs beyond appetite suppression.

sbrothy
Gold Member
Messages
1,758
Reaction score
1,500
TL;DR
NIH-funded research identifies new mechanism of action for next-generation weight-loss drugs
Oral Small-Molecule GLP-1 Drugs Penetrate Deep Into the Brain to Suppress Cravings ((NIH)-funded study, post from May 6, 2026)..

This paper is somewhat over my paygrade but I found it interesting for a couple of reasons:

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain. This newly charted pathway — separate from previously described mechanisms that broadly affect appetite — could be an avenue by which GLP-1s treat other dysfunctions in reward processing, such as substance use disorder.

Also:

To gain a better understanding, the authors modified the GLP-1 receptors of mice with gene-editing techniques, making them more humanlike.

I know it's very abstract but the last comment there kinda gave me goosebumps. "Humanlike"?! :smile:

EDIT: With "over my paygrade" I meant the actual research paper
 
Last edited:
Biology news on Phys.org
sbrothy said:
I know it's very abstract but the last comment there kinda gave me goosebumps. "Humanlike"?! :smile:
Transgenic mouse production fairly common now.
This means that in mice you can switch in human versions of a gene for the mouse version.
In this case, they are talking about replacing mouse GLP receptor gene(s) with the human version.
This is done for purposes of drug testing on human gene products without having to deal with those troublesome humans and their compliance rules.
 
  • Like
Likes   Reactions: sbrothy
BillTre said:
Transgenic mouse production fairly common now.
This means that in mice you can switch in human versions of a gene for the mouse version.
In this case, they are talking about replacing mouse GLP receptor gene(s) with the human version.
This is done for purposes of drug testing on human gene products without having to deal with those troublesome humans and their compliance rules.
Aah. I knew it made sense. To a layman it just sounded like pure scifi at first glance. Thanks for clearing that up.

EDIT: Although now I think about it "transgenic mouse production" doesn't sound much better. o0)
 
Scanning through the actual paper (to say I read it would be an overstatement) I'm impressed with how far biochemistry has come since the four-humours "theory".

I'm still reeling a little from reading that "biography of cancer", "The Emperor of all Maladies".
 

Similar threads

  • · Replies 8 ·
Replies
8
Views
3K
  • · Replies 3 ·
Replies
3
Views
7K
  • · Replies 2 ·
Replies
2
Views
5K